Blog — healthy aging

Explore the vital role of estrogen in perimenopause, its impact on mood, sleep, heart and bone health, and the latest research on hormone therapy options.

Title: Understanding CardioMetabolic Risk – A Silent Threat We Can’t Ignore The rise in cardiovascular disease (CVD), obesity, and type 2 diabetes (DM2) is one of the most pressing health concerns of our time. CVD remains the leading cause of death for both men and women in the United States. Alarmingly, obesity and insulin resistance—precursors to DM2—significantly increase the risk of developing CVD. Yet, these conditions are largely preventable with early detection and lifestyle changes. So, how can we spot the danger before it's too late? What is CardioMetabolic Risk? Cardiometabolic risk refers to a cluster of modifiable risk factors...

By Dr. Sherry LaBeck of ZRT Lab Perimenopause is the transition between a woman's reproductive years and menopause, characterized by a decline in estrogen levels, which can lead to physical and emotional symptoms. Understanding the role of estrogen during this phase is essential for managing symptoms and improving the quality of life for women going through this transition. What is Perimenopause? Perimenopause typically begins in a woman's 40s, though some may experience symptoms as early as their mid-30s, which is known as premature menopause. During this phase, the ovaries produce less estrogen until menstruation stops, marking the onset of menopause....